DOT publishes guidance for updating drug and alcohol policies in light of recent opioid testing update
On Jan. 1, 2018, the U.S. Department of Transportation (DOT) will expand its current panel to require testing for semi-synthetic opioids. The semi-synthetic drugs that must be tested for are: hydrocodone, hydromorphone, oxymorphone, and oxycodone. Read More
U.S. DOT clarifies that medical marijuana is not an excuse in regulated drug testing
The U.S. Department of Transportation (DOT) recently reminded agencies that using medical cannabis with a doctor’s recommendation in accordance with state law is no excuse for failing a drug test. Read More
DOT to add opioids to transportation worker drug testing panel
The Department of Transportation (DOT) will expand its current panel to include testing for semi-synthetic opioids hydrocodone, hydromorphone, oxymorphone and oxycodone. Read More
Department of Transportation proposes amendments to drug testing program
The Department of Transportation (DOT) published a notice in the Federal Register proposing to amend its drug testing program to add four opioids to its drug testing panel. Read More
DOT broadens drug testing requirements to include temporary truck drivers
Newly released enforcement guidance from the U.S. Department of Transportation’s Federal Motor Carrier Safety Administration (FMCSA) made clear that drug and alcohol testing requirements for truck drivers now extend to commercial driver staffing agencies. Read More